Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human MYLK2 Antibodies:
anti-Mouse (Murine) MYLK2 Antibodies:
anti-Rat (Rattus) MYLK2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal MYLK2 Primary Antibody for IHC, IHC (p) - ABIN4337130
Ding, Wang, Sui, Zhao, Xu, Li, Wang, Li, Zhou, Kong: Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue. in Journal of human genetics 2016
Human Polyclonal MYLK2 Primary Antibody for ELISA, WB - ABIN4337128
Graham, Wang, Clayburgh, Cheng, Yoon, Wang, Lin, Turner et al.: Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase ... in The Journal of biological chemistry 2006
Chinese family with dual LQT1 (show KCNQ1 Antibodies) and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1 (show KCNQ1 Antibodies), MYH7 (show MYH7 Antibodies), MYLK2, and TMEM70 (show TMM70 Antibodies) mutations.
This study demonstrates that cyclic stretch disrupts tight junctions and adherens junctions by a JNK2 (show MAPK9 Antibodies), c-Src (show SRC Antibodies), and MLCK (show MYLK Antibodies)-dependent mechanism.
Biochemical and physiological regulation of cardiac myocyte contraction by cardiac-specific myosin light chain kinase (show MYLK3 Antibodies).
These findings suggest that hepatitis B virus X protein disrupts stress fiber formation and triggers apoptosis via an MLCK (show MYLK Antibodies) and a PTEN (show PTEN Antibodies)-dependent pathway.
the P2X1 (show P2RX1 Antibodies)-ERK2 (show MAPK1 Antibodies)-Myosin Light Chain Kinase (show MYLK Antibodies) axis contributes to collagen-induced platelet activation by enhancing platelet degranulation
These data suggest that the kinase domain of MYLK2 is rarely mutated in common human carcinomas and that it does not play a dominant role in cancer pathogenesis.
MYLK (show MYLK Antibodies) gene is a risk factor for the development of acute lung injuries.
Data show that that the prototypical CaM (show CALM1 Antibodies) target sequence skMLCK, a fragment from skeletal muscle myosin light chain kinase (show MYLK Antibodies), binds to CaM (show CALM1 Antibodies) in a highly cooperative way, while only a lower degree of interdomain binding cooperativity emerges for CaMKK (show CAMKK2 Antibodies).
Integrated cDNA expression analysis of failing human myocardia uncovered a novel protein kinase (show CDK7 Antibodies), cardiac-specific myosin light chain kinase (cardiac-MLCK (show MYLK3 Antibodies)), which acts on MLC2v (show MYL2 Antibodies).
data indicate that the IL-1beta (show IL1B Antibodies)-induced increase in MLCK (show MYLK Antibodies) protein expression and Caco-2 TJ permeability was mediated by an increase in MLCK (show MYLK Antibodies) expression and activity and by an NF-kappaB (show NFKB1 Antibodies)-dependent increase in MLCK (show MYLK Antibodies) gene transcription
Phosphorylation of cardiac myosin heavy chains (see MYH7B, MIM 609928) and light chains (see MYL2, MIM 160781) by a kinase, such as MYLK3, potentiates the force and rate of cross-bridge recruitment in cardiac myocytes (Chan et al., 2008
myosin light chain kinase 2, skeletal muscle
, myosin light chain kinase 2, skeletal/cardiac muscle
, myosin light chain kinase 2-like
, skeletal myosin light chain kinase
, myosin, light polypeptide kinase 2
, skeletal muscle MLCK
, MLC kinase
, cardiac-MyBP-C associated Ca/CaM kinase
, cardiac-MyBP-C-associated Ca/CaM kinase
, putative myosin light chain kinase 3